2.50
Hdl Handle:
http://hdl.handle.net/10755/155719
Type:
Presentation
Title:
Lipodystrophy and Quality of Life in HIV: Symptom Management Issues
Abstract:
Lipodystrophy and Quality of Life in HIV: Symptom Management Issues
Conference Sponsor:Sigma Theta Tau International
Conference Year:2004
Conference Date:July 22-24, 2004
Author:Nicholas, Patrice Kenneally, RN, DNSc, MPH, ANP
P.I. Institution Name:Massachusetts General Hospital Institute of Health Professions
Title:Associate Professor
Co-Authors:Kenn M. Kirksey, RN, PhD, APRN, BC; Inge B. Corless, RN, PhD, FAAN; Jeanne Kemppainen, RN, PhD, CNS
The purpose of this study was to examine the incidence and prevalence of lipodystrophy-related symptoms in persons with HIV (n=165) and to examine the impact of these symptoms on health-related quality of life. Since the introduction of highly active antiretroviral therapy (HAART) in HIV disease, the quality of life of persons with HIV is clearly affected across the spectrum of the disease. The sample was composed of 165 persons from three national outpatient HIV settings (clinics and community based organizations) in Boston MA, Fresno CA, and Victoria TX. The descriptive, cross-sectional study included self-report instruments measuring lipodystrophy-associated symptom presence, intensity, and quality of life. The sample was primarily male (75.8%) with ethnicity represented across several groups including African-American (30.9%), Hispanic/Latino (26.7%), Caucasian/Anglo (38.8%), Native American/Indian (1.8%), and other (1.8%). On quality of life measures, only 7.9% of the sample indicated excellent health; 28.5% indicated very good health; 22.4% indicated good health; and over 40% indicated fair or poor health. Most of the participants indicated that their quality of life was good and bad parts about equal in their lives (37.6%). Quality of life was significantly correlated with adequacy of income (r=.241, p=.002), most recent CD4 count (r=-.276, p=.012), and most recent viral load value (r=.379, p=.019). In addition, bodily pain was significantly correlated with most recent CD4 count (r=-.312, p=.004), and with lowest CD4 count (r=-.191, p=.050). The results of the study indicate that quality of life is affected by HIV symptoms and that lipodystrophy may negatively affect quality of life.
Repository Posting Date:
26-Oct-2011
Date of Publication:
22-Jul-2004
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleLipodystrophy and Quality of Life in HIV: Symptom Management Issuesen_GB
dc.identifier.urihttp://hdl.handle.net/10755/155719-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Lipodystrophy and Quality of Life in HIV: Symptom Management Issues</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2004</td></tr><tr class="item-conference-date"><td class="label">Conference Date:</td><td class="value">July 22-24, 2004</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Nicholas, Patrice Kenneally, RN, DNSc, MPH, ANP</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Massachusetts General Hospital Institute of Health Professions</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Associate Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">pnicholas@mghihp.edu</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">Kenn M. Kirksey, RN, PhD, APRN, BC; Inge B. Corless, RN, PhD, FAAN; Jeanne Kemppainen, RN, PhD, CNS</td></tr><tr><td colspan="2" class="item-abstract">The purpose of this study was to examine the incidence and prevalence of lipodystrophy-related symptoms in persons with HIV (n=165) and to examine the impact of these symptoms on health-related quality of life. Since the introduction of highly active antiretroviral therapy (HAART) in HIV disease, the quality of life of persons with HIV is clearly affected across the spectrum of the disease. The sample was composed of 165 persons from three national outpatient HIV settings (clinics and community based organizations) in Boston MA, Fresno CA, and Victoria TX. The descriptive, cross-sectional study included self-report instruments measuring lipodystrophy-associated symptom presence, intensity, and quality of life. The sample was primarily male (75.8%) with ethnicity represented across several groups including African-American (30.9%), Hispanic/Latino (26.7%), Caucasian/Anglo (38.8%), Native American/Indian (1.8%), and other (1.8%). On quality of life measures, only 7.9% of the sample indicated excellent health; 28.5% indicated very good health; 22.4% indicated good health; and over 40% indicated fair or poor health. Most of the participants indicated that their quality of life was good and bad parts about equal in their lives (37.6%). Quality of life was significantly correlated with adequacy of income (r=.241, p=.002), most recent CD4 count (r=-.276, p=.012), and most recent viral load value (r=.379, p=.019). In addition, bodily pain was significantly correlated with most recent CD4 count (r=-.312, p=.004), and with lowest CD4 count (r=-.191, p=.050). The results of the study indicate that quality of life is affected by HIV symptoms and that lipodystrophy may negatively affect quality of life.</td></tr></table>en_GB
dc.date.available2011-10-26T14:06:34Z-
dc.date.issued2004-07-22en_GB
dc.date.accessioned2011-10-26T14:06:34Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.